A new way to strengthen the needle!
Under the Joint Prevention and control mechanism of The State Council, a press conference was held on April 19 to introduce epidemic prevention and control and vaccination work.At present, the epidemic situation in China remains stable on the whole.The genetic sequencing results of this outbreak in Hohhot, Inner Mongolia, show that the Delta mutant strain is a local epidemic caused by a new imported source, which has affected Baotou City, Inner Mongolia.At present, the epidemic is in the early stage, the number of confirmed cases is increasing rapidly, and there are clusters of cases in crowded places such as workplace and wedding banquet, which pose a high risk of community transmission and spillover.The current outbreak in Baise, Guangxi is in the phase of winding down and zeroing out.The newly added cases in Huludao, Liaoning province, were mainly detected through centralized quarantine screening, indicating that the trend of the epidemic is improving and the risk of social transmission is basically under control.The current outbreak in Heihe, Heilongjiang province is mainly concentrated in Heihe City, with multiple transmission chains. Further tracing and case investigation are being carried out in an orderly manner.Clusters of imported cases have been found in Shenzhen, Zhuhai and Dongguan in Guangdong province. The omicron epidemic in Shenzhen has been basically controlled, and the epidemic in Dongguan and Zhuhai is being traced to the source.Under the joint prevention and control mechanism of The State Council, working teams have been dispatched to deal with clusters of cases in Liaoning, Inner Mongolia and Guangdong.As of 18 February, a total of 3.075752 million novel coronavirus vaccine doses were reported nationwide, and 1.232543 million people had completed the full course of vaccination.Recently, with the approval of the Joint prevention and control mechanism of The State Council, the National Health Commission has started to deploy sequential enhanced immunization.Sequential immunization is a vaccination strategy that uses different technical route vaccines or different anti-prototype vaccines at certain intervals and doses in order to obtain better preventive effect and safety.Previously, target groups over 18 years old who received inactivated vaccines from Sinopac Beijing co., LTD., Sinopac Beijing Co., LTD., Sinopac Wuhan Co., LTD., or adenovirus vector vaccines from Tianjin Concino Co., LTD., for six months could receive a dose of secondary homologous enhanced immunization, that is, the original vaccine was strengthened.After the implementation of the sequential enhanced immunization strategy, the target population that has completed the whole vaccination of the three inactivated vaccines mentioned above can also choose the recombinant protein vaccine of Zhiphilongkoma Biopharmaceutic Co., LTD or the adenovirus vector vaccine of Concino for sequential enhanced immunization.For the target population, either homologous booster immunization or sequential booster immunization can be selected.Both homologous booster and sequential booster should be carried out in people over 18 years of age who have completed the full course of vaccination for at least 6 months.Research data show that both homologous and sequential strengthening of immunization can further improve the immunization effect. It is hoped that people who meet the vaccination conditions can take the initiative to vaccinate and vaccinate early, so as to improve their health and fuel the epidemic prevention.Source: News network, Jin Yun